Recruiting NA Cervicogenic Headache

New treatment option for Cervicogenic Headache

Official title Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache

ClinicalTrials.gov ID: NCT07508410

What this study is testing

What it's testing
Cervicogenic headache (CBH) is defined as a headache caused by a disorder in the cervical spine, bones, discs, or soft tissue elements, which is also accompanied by neck pain. Unilateral, non-reversible oculo, fronto, temporal pain, pain that increases with poor neck positioning and incorrect neck movements, and may be seen with restricted movement in the upper cervical and occiput regions.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • Individuals aged 18-65
  • Having experienced neck or headache for 3 months
  • Meeting the diagnostic criteria for cervicogenic headache;
  • Unilateral pain
  • Reduced range of motion in the neck

You likely can't join if

  • Migraine
  • Cluster headache
  • Cervical radiculopathy
  • Entrapment neuropathy
  • Myelopathy
  • Rheumatoid arthritis
See the full eligibility criteria
Who can join
  • Individuals aged 18-65
  • Having experienced neck or headache for 3 months
  • Meeting the diagnostic criteria for cervicogenic headache;
  • Unilateral pain
  • Reduced range of motion in the neck
  • Ipsilateral shoulder discomfort
  • Ipsilateral arm discomfort
  • Pain that worsens with different neck movements and is painful on palpation
What rules you out
  • Migraine
  • Cluster headache
  • Cervical radiculopathy
  • Entrapment neuropathy
  • Myelopathy
  • Rheumatoid arthritis
  • Undergoing cervical spinal surgery
  • Pregnant women
  • Those who received physical therapy within 6 months
  • Those with a history of major psychiatric illness
  • Those with a history of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological)
  • Those with a history of uncontrolled systemic endocrine diseases (dm, hyperthyroidism)

The study team makes the final eligibility decision.

Where it's taking place

  • Konya, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.